SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-17-003260
Filing Date
2017-12-08
Accepted
2017-12-08 09:20:11
Documents
51
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cannabics_10k-083117.htm 10-K 667905
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER cannabics_ex3101.htm EX-31.1 10435
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER cannabics_ex3102.htm EX-31.2 10548
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER cannabics_ex3201.htm EX-32.1 4108
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER cannabics_ex3202.htm EX-32.2 4201
  Complete submission text file 0001683168-17-003260.txt   2298095

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cnbx-20170831.xml EX-101.INS 314797
7 XBRL SCHEMA FILE cnbx-20170831.xsd EX-101.SCH 21206
8 XBRL CALCULATION FILE cnbx-20170831_cal.xml EX-101.CAL 36220
9 XBRL DEFINITION FILE cnbx-20170831_def.xml EX-101.DEF 69800
10 XBRL LABEL FILE cnbx-20170831_lab.xml EX-101.LAB 160890
11 XBRL PRESENTATION FILE cnbx-20170831_pre.xml EX-101.PRE 135704
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52403 | Film No.: 171246199
SIC: 2834 Pharmaceutical Preparations